ɬÀï·¬

Journal News

ɬÀï·¬: We shall know
thine enemy, honey bee

John Arnst
Nov. 1, 2017

Varroa destructor is appropriately named, given the havoc it wreaks on colonies of western honey bees. Since it first arrived in Florida in the 1980s, the parasitic mite has pushed bee colonies across North America to ruin, and it is believed to be the most significant contributor to the recent spike in colony deaths in the United States and . Despite the scope of the mite’s damage, however, surprisingly little is known about its inner molecular workings.

A western honey bee rests on a flower. RICKS/WIKIMEDIA COMMONS

As a first step in ultimately combating this bee-barian, researchers in the lab of at the University of British Columbia in Canada have published in Molecular & Cellular Proteomics that details 1,433 differentially expressed proteins across the various developmental stages of V. destructor.

“One thing that a lot of people who are studying model systems or human systems don’t really appreciate is that when you move outside of those model systems and try to understand something at a molecular level about an organism without that huge body of knowledge that has been built over the years in that particular organism, you really don’t have any idea where to start,” Foster said. With this in mind, Foster and colleagues, including graduate student Alison McAfee, set out to create a document of the entire proteome that the male and female mites might produce throughout their life cycles.

“It’s a tool that other researchers can use to come up with their own questions about Varroa biology,” said McAfee, whose research focuses on the defense mechanisms bees mount against the mites.

In addition to quantifying the mites’ proteins, the researchers found that males and females expressed proteins involved in chromatin remodeling differently.

“Very little is known about the sex determination system in Varroa,” McAfee said. “Part of what that might be pointing to is the mites exposing different parts of the DNA to express more sex-specific proteins.”

The harm that V. destructor inflicts on honey bees is multifold; in addition to feasting on the bees’ blood and leaving open wounds ripe for infection, the mites are vectors for the deformed wing virus, which cripples wing growth in developing honey-bee pupae.

The scope of damage from mites is a consequence of abrupt introductions — the longer a host and parasite have coexisted and coevolved, the more harmonious, if still exploitative, their relationship will be.

Such is the case with V. destructor and its original host, the Asian honey bee, which have had millions of years to get to know one another. However, V. destructor and its viruses have just barely begun to make evolutionary introductions with honey bees, giving their new hosts few genetic weapons to fight them off.

According to Foster, Varroa’s use of odorant-binding proteins is likely key to their predatory interactions.

“Varroa have to be able to detect bees of certain ages, and this has to depend on odors,” he said. “At some point, we will want to try to define the molecular mechanism that is underlying that interaction, and knowing which proteins are expressed in which stages in the Varroa will be important for that eventual understanding.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
John Arnst

John Arnst was a science writer for ASBMB Today.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

What’s in a diagnosis?
Essay

What’s in a diagnosis?

Sept. 4, 2025

When Jessica Foglio’s son Ben was first diagnosed with cerebral palsy, the label didn’t feel right. Whole exome sequencing revealed a rare disorder called Salla disease. Now Jessica is building community and driving research for answers.

Peer through a window to the future of science
Annual Meeting

Peer through a window to the future of science

Sept. 3, 2025

Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.

Glow-based assay sheds light on disease-causing mutations
Journal News

Glow-based assay sheds light on disease-causing mutations

Sept. 2, 2025

University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.

How signals shape DNA via gene regulation
Journal News

How signals shape DNA via gene regulation

Aug. 19, 2025

A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent ɬÀï·¬ paper.

A game changer in cancer kinase target profiling
Journal News

A game changer in cancer kinase target profiling

Aug. 19, 2025

A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent ɬÀï·¬ paper.

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.